Physician profile
Christopher G Olson
NPI 1265422448
$530,366.68
in general payments reported to CMS, 2019-2025
48 companies · $7,645 in 2025
The $7,645 reported for 2025 was more than what 98% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,646 · 2020: $20K · 2021: $185K · 2022: $197K · 2023: $93K · 2024: $25K · 2025: $7,645.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $89K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $25K · Travel and Lodging: $8,676 · Food and Beverage: $3,379.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $88,812.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $25,235.14 |
| Travel and Lodging | $8,675.90 |
| Food and Beverage | $3,379.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acessa Health INC. | $432,078.03 | 2019-2024 | Acessa Provu System |
| Abbvie INC. | $41,385.38 | 2019-2025 | |
| Dysis Medical, INC. | $21,955.59 | 2019-2022 | |
| Allergan, INC. | $18,158.24 | 2019-2023 | |
| Hologic Sales and Service, LLC | $5,864.33 | 2020-2025 | Acessa Provu System |
| Agile Therapeutics, INC. | $5,093.37 | 2021-2022 | |
| Channel Medsystems, INC. | $1,688.40 | 2023-2025 | |
| Astellas Pharma US INC | $519.42 | 2022-2025 | Veozah, Myrbetriq |
| Amgen INC. | $446.51 | 2019-2025 | Evenity, Prolia |
| Pfizer INC. | $344.39 | 2019-2023 | |
| Allotrope Medical, INC | $342.35 | 2021 | |
| Mayne Pharma Commercial LLC | $256.27 | 2022-2025 | |
| Therapeuticsmd, INC. | $207.52 | 2019-2022 | |
| Avion Pharmaceuticals | $170.64 | 2019-2022 | |
| Gynesonics, INC. | $159.32 | 2022-2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Olson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.